Fractyl Health, Inc. Common Stock (GUTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.99M
Last updated: Nov 17, 2026 at 11:05 AM ET
Fractyl Health, Inc. Common Stock (GUTS) Stock Forecast
Analysts expect Fractyl Health, Inc. Common Stock (GUTS) to earn -$3.53 per share in the fiscal year ending Dec 31, 2026. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 6 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Dec 31, 2026
- -$3.53
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$3.31
- EPS consensus, revenue $1.30M
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.53 | -$3.53 to -$3.53 | 1 | N/A | N/A | 5 |
| Dec 31, 2027 | -$3.31 | -$5.79 to -$0.72 | 3 | $1.30M | N/A | 4 |
Quarterly Estimates
The EPS consensus rises from -$1.38 for the quarter ending Dec 31, 2026 to -$0.89 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.38 | -$1.76 to -$1.13 | 7 |
| Mar 31, 2027 | -$0.89 | -$1.52 to -$0.25 | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 1 | 2 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.53 | -$3.92 | -$3.98 | -$3.96 | -$3.96 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.31 | -$3.62 | -$4.78 | -$5.26 | -$5.26 | N/A |
| Quarter ending Mar 31, 2027 | -$0.89 | -$0.86 | -$1.26 | -$1.26 | -$1.68 | N/A |
Frequently Asked Questions About GUTS
What is the GUTS stock forecast?
Consensus analyst estimates put Fractyl Health, Inc. Common Stock's EPS at -$3.53 for the fiscal year ending Dec 31, 2026. The consensus rating from 6 analysts is Buy.
How do analysts rate GUTS stock?
Of 6 analysts covering Fractyl Health, Inc. Common Stock, 0 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from GUTS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.53, with estimates from -$3.53 to -$3.53 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.31, with estimates from -$5.79 to -$0.72 from 3 analysts.
What revenue do analysts expect from Fractyl Health, Inc. Common Stock next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.30M.
How many analysts cover GUTS?
6 analysts rate Fractyl Health, Inc. Common Stock stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
GUTS pages: Overview, Earnings, Forecast, Financials, Competitors